©The Author(s) 2024.
World J Clin Cases. Jul 16, 2024; 12(20): 4041-4047
Published online Jul 16, 2024. doi: 10.12998/wjcc.v12.i20.4041
Published online Jul 16, 2024. doi: 10.12998/wjcc.v12.i20.4041
Table 1 General information on the study population, n (%)
| Group | Cases | Controls | χ2/T | P value | |
| Age (yr) | 6.00 ± 1.51 | 5.94 ± 1.51 | −9.880 | 0.214 | |
| Adenoid grade | IV | 14 (16.47) | 8 (9.40) | 13.458 | 0.004 |
| III | 21 (24.71) | 7 (8.20) | |||
| II | 30 (35.29) | 34 (40.00) | |||
| I | 20 (23.53) | 36 (42.4) | |||
| Tonsil grade | IV | 23 (27.06) | 9 (10.59) | 17.215 | 0.001 |
| III | 23 (27.06) | 11 (12.94) | |||
| II | 18 (21.28) | 26 (30.59) | |||
| I | 21 (24.71) | 39 (45.88) | |||
| Sinusitis | Yes | 56 (65.88) | 18 (21.18) | 34.555 | 0.000 |
| No | 29 (34.12) | 67 (78.82) | |||
| Rhinitis | Yes | 46 (54.12) | 13 (15.29) | 28.268 | 0.000 |
| No | 39 (45.88) | 72 (84.71) | |||
| BMI | 26.87 ± 0.95 | 26.34 ± 0.92 | -8.121 | 0.264 |
- Citation: He W, Cheng Q. Risk factors and management countermeasures for obstructive sleep apnea hypoventilation syndrome in children. World J Clin Cases 2024; 12(20): 4041-4047
- URL: https://www.wjgnet.com/2307-8960/full/v12/i20/4041.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v12.i20.4041